Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166.

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no cure and limited treatment options.

The TikTok star, 37, was officially diagnosed with the terminal neurodegenerative disease in 2022 ...

New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI computational models that predict the degeneration of neural networks in amyotrophic ...

A recent large study conducted in Sweden has found that long-term exposure to elevated levels of air pollution may increase ...

A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...

Please provide your email address to receive an email when new articles are posted on . The treatment group logged longer times to four disease-progression milestones compared with controls. At 2 ...

Over the course of the last three years, Brooke Eby has documented the progression of her condition for an audience of over 300,000 social media followers Courtesy of Brooke Eby Brooke Eby was ...

Target ALS has launched a new website that offers improved accessibility to patients, researchers, and the ALS community at ...

Add Yahoo as a preferred source to see more of our stories on Google. When I was interviewed on the Today show in 2023, I told Savannah Guthrie, "Levity is my superpower." It's true, although before I ...